Literature DB >> 2392325

Expression of the TGF alpha integral membrane precursor induces transformation of NRK cells.

A J Blasband1, D M Gilligan, L F Winchell, S T Wong, N C Luetteke, K T Rogers, D C Lee.   

Abstract

TGF alpha is one member of a family of soluble growth factors that are derived from integral-membrane precursors. The mature form of TGF alpha is released from its transmembrane precursor (proTGF alpha) by a protease that, in many tumor cells, is inefficient or limiting. We have previously established that, in the absence of processing, membrane-anchored proTGF alpha is biologically active and can interact with the EGF receptor on adjacent cells, thereby inducing the receptor's intrinsic tyrosine kinase activity. We further showed that this interaction leads to immediate downstream signal transduction as evidenced by Ca2+ mobilization. To extend these observations, and to investigate its transforming potential, we infected normal rat kidney (NRK) cells with retroviral expression vectors that encode mutated forms of proTGF alpha containing amino acid substitutions at the proteolytic cleavage sites. NRK cells harboring these mutant constructs do not secrete mature growth factor, but do express biologically active proTGF alpha on the cell surface as shown by their ability to induce the autophosphorylation of EGF receptor on neighboring A431 cells in co-culture. Expression of the mutant proTGF alpha molecules promoted the anchorage-independent growth of NRK cells in soft agar, and caused them to be tumorigenic when injected into nude mice. These results demonstrate that an interaction between EGF receptor and the integral membrane precursor to TGF alpha can provide a mitogenic stimulus that leads to transformation. They further suggest that the accumulation of proTGF alpha on the surface of some transformed cells has physiological relevance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2392325

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Transforming growth factor-alpha precursors in human colon carcinoma cells.

Authors:  M Asbert; B Montaner; R Pérez-Tomás
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

2.  The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing.

Authors:  G P Briley; M A Hissong; M L Chiu; D C Lee
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

3.  Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.

Authors:  N Redemann; B Holzmann; T von Rüden; E F Wagner; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

4.  Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.

Authors:  E P Sandgren; N C Luetteke; T H Qiu; R D Palmiter; R L Brinster; D C Lee
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

Review 5.  EGF receptor in neoplasia and metastasis.

Authors:  K Khazaie; V Schirrmacher; R B Lichtner
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

6.  EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?

Authors:  Robert A Fenstermaker; Michael J Ciesielski
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

7.  Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations.

Authors:  S A Halter; P Dempsey; Y Matsui; M K Stokes; R Graves-Deal; B L Hogan; R J Coffey
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

8.  Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytes.

Authors:  Olivier Nolan-Stevaux; Morgan C Truitt; Jessica C Pahler; Peter Olson; Cristina Guinto; David C Lee; Douglas Hanahan
Journal:  Genes Cancer       Date:  2010-02

9.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.

Authors:  S Higashiyama; R Iwamoto; K Goishi; G Raab; N Taniguchi; M Klagsbrun; E Mekada
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.